Department of Neurology, Behavioral Neurology Section, University of Colorado School of Medicine, Aurora, Colo. (Pressman); Department of Medicine, Division of Geriatric Medicine, University of Colorado School of Medicine, Aurora, Colo. (Matlock); and Montreal Neurological Institute-Hospital, Montreal (Ducharme).
J Neuropsychiatry Clin Neurosci. 2021 Spring;33(2):152-156. doi: 10.1176/appi.neuropsych.20090238. Epub 2021 Jan 14.
The behavioral variant of frontotemporal dementia (bvFTD) is the second most common cause of dementia for individuals <65 years old, but accurate diagnosis is often delayed for several years. While previous criteria have increased the ability of diagnosticians to distinguish between bvFTD and other neurocognitive disorders such as Alzheimer's disease, distinguishing bvFTD from a primary psychiatric disorder (PPD) has been more challenging. In early 2020, the Neuropsychiatric International Consortium for Frontotemporal Dementia published the first consensus recommendations to help clinicians distinguish between bvFTD and PPD. These recommendations were produced by a consortium of 45 scientists and clinicians from more than 15 different countries, who explored aspects of history taking, neuropsychological assessments, clinical scales, neuroimaging, CSF and serum biomarkers, and genetics. A multidisciplinary approach is encouraged throughout. In this article, the authors also review those consensus recommendations and highlight use of novel tests and techniques. Additionally, they indicate where further research is needed, including methods to assess the dissemination and implementation of these recommendations. In this way, future efforts by clinicians and researchers alike to improve accurate recognition of bvFTD are encouraged, thereby expanding opportunities for improved guidance and management.
行为变异型额颞叶痴呆(bvFTD)是 65 岁以下人群第二常见的痴呆症病因,但准确诊断通常会延迟数年。尽管之前的标准提高了诊断人员区分 bvFTD 和其他神经认知障碍(如阿尔茨海默病)的能力,但区分 bvFTD 和原发性精神障碍(PPD)更具挑战性。2020 年初,神经精神病学国际额颞叶痴呆联合会发布了首个有助于临床医生区分 bvFTD 和 PPD 的共识建议。这些建议由来自 15 个以上不同国家的 45 名科学家和临床医生组成的联合会制定,他们探讨了病史采集、神经心理学评估、临床量表、神经影像学、CSF 和血清生物标志物以及遗传学等方面。鼓励采用多学科方法。在本文中,作者还回顾了这些共识建议,并强调了新型测试和技术的使用。此外,他们还指出了需要进一步研究的地方,包括评估这些建议的传播和实施的方法。通过这种方式,鼓励临床医生和研究人员共同努力,提高 bvFTD 的准确识别,从而为改善指导和管理提供更多机会。